September 19, 2014 8:45 AM ET

Pharmaceuticals

Company Overview of InCarda Therapeutics, Inc.

Executive Profile

Raymond John Lipicky M.D.

Member of Advisory Board, InCarda Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 5 different industries.

See Board Relationships
----

Background

Dr. Raymond John Lipicky, M.D. served as Director of the Division of Cardio-Renal Drug Products at the Food and Drug Administration. Dr. Lipicky is a regulatory Affairs Consultant. He serves as a Member of Scientific Advisory Board at Milestone Pharmaceuticals Inc. He serves as a Member of Clinical Advisory Board of Angiogenix Inc. and ARMGO Pharma, Inc. He serves as Member of Advisory Board of InCarda Therapeutics, Inc. He serves as Scientific Advisor of Surgery of ...

Corporate Headquarters

150 Post Street
San Francisco, California 94108

United States

Phone: 650-798-5000
Fax: 650-798-5001

Board Members Memberships

There is no Board Members Memberships data available.

Education

MD
University of Cincinnati
Unknown/Other Education
University Of Cincinnati College Of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact InCarda Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.